Almost Family (NASDAQ: AFAM) is in the home health nursing service business and offers senior citizens in nine states an alternative to spending their days in nursing homes. As the aging Baby Boomer generation looks to keep a level of independence without sacrificing their level of care, Almost Family is a perfect fit.

Almost Family has been buying up local providers to grow its share of the highly fragmented market and increase its margins. Clearly, this strategy is working, as the company's earnings rose 55% to 68 cents per share, compared with 44 cents per share in the first quarter of 2008. What's more, AFAM's revenue increased by a whopping 77% to $69.2 million from $39 million. Analysts on average were expecting earnings of 60 cents per share on revenue of 63 million, so Almost Family posted a 13.3% earnings surprise and a 9.8% sales surprise.

Small-cap stocks are a GREAT place to start if you're serious about rebuilding your wealth and securing your financial future.

But what makes small-cap stocks so spectacular?

The bear market stripped analysts from small stocks -- hardly anyone is covering them anymore. This creates wonderful pricing anomalies and gives the individual investor a significant edge.

MOST NOTEWORTHY: Almost Family, Cooper Industries and Ciber were today's noteworthy initiations:

• Jefferies believes Almost Family (NASDAQ: AFAM) will likely take advantage of the significant consolidation opportunity in home nursing. The firm started shares with a Buy rating and $26 target.
  
• Kevin Dann initiated Cooper Industries (NYSE: CBE) with a Sell rating and $35 target and believes the upcoming growth deceleration in North America, Europe and Asia's developed regions could weigh on sales growth and further margin expansion.
  
• Ciber (NYSE: CBR) was assumed with a Buy rating and $9 target at Roth Capital, as they view the company as a compelling investment opportunity for value investors. The firm recommends building positions.

OTHER INITIATIONS:

• BMO Capital initiated Bionovo (NASDAQ: BNVI) with a Market Perform rating.
  
• Goldman reinstated Live Nation (NYSE: LYV) with a Buy rating and $15 target.
  
• Canaccord Adams started Amalyin Pharma (NASDAQ: AMLN) with a Sell rating and $23 target.